Statins and the primary prevention of cardiovascular events
Data up to Jan 2025
Total Citations Per Year
Abstract
References (44)
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
2017 • 28,714 citations
Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
1993 • 28,274 citations
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
2001 • 24,089 citations
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 • 7,378 citations
The global burden of disease: a comprehensive assessment of mortality and disability from diseases injuries and risk factors in 1990 and projected to 2020.
1996 • 7,011 citations
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
2004 • 6,926 citations
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 • 6,780 citations
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
2005 • 6,633 citations
Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels
1998 • 5,293 citations
Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes
2003 • 4,328 citations
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 • 3,816 citations
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
2004 • 3,776 citations
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
1995 • 3,524 citations
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 • 3,347 citations
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
2003 • 2,283 citations
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 • 2,192 citations
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
2001 • 1,999 citations
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 • 1,880 citations
Risks for All-Cause Mortality, Cardiovascular Disease, and Diabetes Associated With the Metabolic Syndrome
2005 • 1,657 citations
A strategy to reduce cardiovascular disease by more than 80%
2003 • 1,553 citations
Measurement of C-Reactive Protein for the Targeting of Statin Therapy in the Primary Prevention of Acute Coronary Events
2001 • 1,537 citations
Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
2003 • 1,509 citations
Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
2002 • 1,311 citations
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study
1999 • 973 citations
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events
2001 • 783 citations
Parental Cardiovascular Disease as a Risk Factor for Cardiovascular Disease in Middle-aged Adults
2004 • 755 citations
Should C-Reactive Protein Be Added to Metabolic Syndrome and to Assessment of Global Cardiovascular Risk?
2004 • 648 citations
The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
2004 • 543 citations
Optimal low-density lipoprotein is 50 to 70 mg/dl
2004 • 465 citations
Rosuvastatin in the Primary Prevention of Cardiovascular Disease Among Patients With Low Levels of Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein
2003 • 427 citations
Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients With Acute Coronary Syndromes
2004 • 324 citations
Metabolic Syndrome: Risk factor distribution and 18-year mortality in the Multiple Risk Factor Intervention Trial
2006 • 153 citations
Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome
2003 • 152 citations
Cardiovascular Disease in U.S. Patients With Metabolic Syndrome, Diabetes, and Elevated C-Reactive Protein
2005 • 145 citations
Estimating the Benefits of Modifying Risk Factors of Cardiovascular Disease
1998 • 145 citations
Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III.
2001 • 121 citations
Metabolic Syndrome
2006 • 120 citations
Additive Benefits of Pravastatin and Aspirin to Decrease Risks of Cardiovascular Disease
2004 • 107 citations
Statin and β-Blocker Therapy and the Initial Presentation of Coronary Heart Disease
2006 • 86 citations
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Ridker PM, Buring JE, Cook NR, Rifai NR. Circulation 2003; 107: 391-397.
2003 • 40 citations
Implications from the Air Force/Texas Coronary Atherosclerosis Prevention Study for the Adult Treatment Panel III Guidelines
2005 • 29 citations
Association of the Metabolic Syndrome With Early Coronary Disease in Families With Frequent Myocardial Infarction
2006 • 19 citations
Post-hospitalization management of high-risk coronary patients
2000 • 10 citations
Deleted Work
1955 • 0 citations